Skip to main content

Regulatory and Washington

  • NCPA brings back diabetes management, long-term care workshops

    ALEXANDRIA, Va. — The National Community Pharmacists Association has renewed two of its pharmacy niche programs.

  • NRF to policy-makers: Don't broaden cybersecurity legislation

    WASHINGTON — Two bills designed to protect "covered critical infrastructure" against cyber attacks by terrorists and others should remain focused on their key purpose and not be expanded to include data breach legislation or broad new privacy regimes, the National Retail Federation said.

  • PCMA drug diversion ad draws criticism

    ALEXANDRIA, Va. — An organization representing independent retail pharmacies is criticizing a new ad by a pharmacy benefit manager industry group, calling the ad "irresponsible."

  • CDC's latest weekly flu report: Still no season to speak of to date

    ATLANTA — The Centers for Disease Control and Prevention on Friday issued its latest update on the influenza season to date, or rather the lack thereof. For the week ended Feb. 25, visits for influenza-like illnesses have yet to crack the national baseline of 2.4% this season.

    Over the past two seasons, 2009/2010 and 2010/2011, reports of ILI activity reached levels approaching 8% and 5%, respectively, after crossing over that 2.4% threshold — an indicator that the flu season is well under way.

  • FDA approves first flu vaccine to treat four strains of virus

    SILVER SPRING, Md. — The Food and Drug Administration has approved what it called the first flu vaccine to prevent four strains of the influenza virus.

  • PTCB names retired Air Force colonel as CEO, executive director

    WASHINGTON — The country's largest organization that certifies pharmacy technicians has a new leader.

    The Pharmacy Technician Certification Board announced Thursday the selection of retired Air Force colonel Everett McAllister as its new executive director and CEO, replacing interim executive director William Schimmel, who will return to his role of associate director.

  • American Diabetes Association responds to FDA's warning on safety of statins

    ALEXANDRIA, Va. — The American Diabetes Association said it is urging people with diabetes who currently are taking a statin to continue their medication unless instructed otherwise by their healthcare provider.

  • FDA approves two new drugs for pancreatic disorders

    SILVER SPRING, Md. — The Food and Drug Administration has approved two new drugs for pancreatic disorders, the agency said Thursday.

    The FDA announced the approval of Aptalis Pharma's Ultresa and Viokase, both generically known as pancrelipase. Ultresa is a delayed-release capsule for children and adults with cystic fibrosis, which affects the lungs and other organs, while Viokase is meant for use with a proton-pump inhibitor in adults who can't digest food because of pancreatitis or surgical removal of the pancreas.

X
This ad will auto-close in 10 seconds